Manufacturer
Aurobindo Pharma Limited, Unit-VII (SEZ)
Contents
Moxifloxacin 400mg
Indication
Community-acquired pneumonia, Acute bacterial exacerbation of chronic bronchitis, Acute bacterial sinusitis, Pelvic inflammatory disease, Complicated skin and skin structure infections
Instruction
May be taken with or without food.
Drug interaction
Increased risk of bradycardia with potassium-reducing agents (e.g. loop diuretics). Increased risk of tendon disorder with corticosteroids. Decreased absorption by forming chelates with antacids containing Al, Mg, Fe, sucralfate and multivalent cations. May enhance anticoagulant effects of warfarin.Potentially Fatal: Increased risk of QT prolongation with class IA (e.g. quinidine) and class III (e.g. amiodarone) antiarryhthmics, terfenadine, cisapride, erythromycin, antipsychotics (e.g. haloperidol), and TCA (e.g. amitriptyline).
Malaysia
